FDA Inspection
Cambrex Profarmaco Milano SrlCambrex Profarmaco Milano Srl – FDA Inspection, Nov 11, 2022
Record Details
This FDA Inspection record concerns Cambrex Profarmaco Milano Srl, with an inspection on November 11, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 11, 2022
- Product Type
- Drugs
View Company Profile
ID · d517f310-c80c-4a43-a918-722116697891
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1193220
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Cambrex Profarmaco Milano Srl
7| Date | Classification | Office | Project area |
|---|---|---|---|
| October 1, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 7, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 19, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 6, 2013 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Cambrex Profarmaco Milano Srl
- FDA Inspection 1167505 - 2021-10-01
- FDA Inspection 1091698 - 2019-05-07
- FDA Inspection 1021644 - 2017-05-19
- FDA Inspection 973972 - 2015-11-06
- FDA Inspection 861141 - 2013-12-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.